AU2002230390A1 - Ixodes scapularis tissue factor pathway inhibitor - Google Patents
Ixodes scapularis tissue factor pathway inhibitorInfo
- Publication number
- AU2002230390A1 AU2002230390A1 AU2002230390A AU3039002A AU2002230390A1 AU 2002230390 A1 AU2002230390 A1 AU 2002230390A1 AU 2002230390 A AU2002230390 A AU 2002230390A AU 3039002 A AU3039002 A AU 3039002A AU 2002230390 A1 AU2002230390 A1 AU 2002230390A1
- Authority
- AU
- Australia
- Prior art keywords
- tissue factor
- pathway inhibitor
- factor pathway
- ixodes scapularis
- scapularis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000238703 Ixodes scapularis Species 0.000 title 1
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 title 1
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24057500P | 2000-10-05 | 2000-10-05 | |
US60/240,575 | 2000-10-05 | ||
PCT/US2001/042472 WO2002033089A2 (fr) | 2000-10-05 | 2001-10-05 | Inhibiteur de la voie de facteur tissulaire d'ixodes scapularis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002230390A1 true AU2002230390A1 (en) | 2002-04-29 |
Family
ID=22907098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002230390A Abandoned AU2002230390A1 (en) | 2000-10-05 | 2001-10-05 | Ixodes scapularis tissue factor pathway inhibitor |
Country Status (3)
Country | Link |
---|---|
US (1) | US7078508B2 (fr) |
AU (1) | AU2002230390A1 (fr) |
WO (1) | WO2002033089A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7528227B2 (en) * | 2004-03-23 | 2009-05-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Histone H2A peptide derivatives and uses thereof |
US20050123554A1 (en) * | 2002-04-29 | 2005-06-09 | The Board Of Regents For Oklahoma State University | Protective antigens and vaccines for the control of multi species tick infestations |
WO2006042017A2 (fr) * | 2004-10-06 | 2006-04-20 | University Of Rochester | Traitement de l'hypertension pulmonaire au moyen d'un agent inhibant une voie du facteur tissulaire |
KR101977846B1 (ko) | 2008-12-19 | 2019-05-14 | 박스알타 인코퍼레이티드 | Tfpi 억제제 및 사용 방법 |
US8772238B2 (en) | 2009-03-18 | 2014-07-08 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer |
JP5730983B2 (ja) * | 2010-03-19 | 2015-06-10 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Tfpi阻害剤および使用方法 |
GB2485590A (en) * | 2010-11-22 | 2012-05-23 | Univ Ruprecht Karis Heidelberg | Method for detecting at least one direct factor Xa inhibitors |
CA2867363C (fr) | 2012-03-21 | 2023-02-28 | Baxter International Inc. | Inhibiteurs de la voie du facteur tissulaire (tfpi) et procedes d'utilisation |
NZ703148A (en) | 2012-07-25 | 2016-08-26 | Catalyst Biosciences Inc | Modified factor x polypeptides and uses thereof |
KR101909052B1 (ko) * | 2017-02-09 | 2018-10-17 | 강원대학교산학협력단 | 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US5453492A (en) * | 1993-07-28 | 1995-09-26 | La Jolla Cancer Research Foundation | 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β |
US5837458A (en) * | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
EP0871705A4 (fr) * | 1995-06-05 | 2000-01-26 | Human Genome Sciences Inc | Facteur de croissance humain du type ccn |
ATE338120T2 (de) * | 1998-11-27 | 2006-09-15 | Ucb Sa | Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung |
-
2001
- 2001-10-05 AU AU2002230390A patent/AU2002230390A1/en not_active Abandoned
- 2001-10-05 WO PCT/US2001/042472 patent/WO2002033089A2/fr active Application Filing
-
2003
- 2003-04-04 US US10/408,166 patent/US7078508B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2002033089A3 (fr) | 2004-02-26 |
US7078508B2 (en) | 2006-07-18 |
WO2002033089A2 (fr) | 2002-04-25 |
US20040018516A1 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001288610A1 (en) | Feminine hygiene kit | |
AU2002216311A1 (en) | Surgical reamer | |
AU2001229583A1 (en) | Bone drill | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001259237A1 (en) | Reverse keno | |
GB0020276D0 (en) | Dermatological composition | |
AU2002220241A1 (en) | Parb inhibitors | |
AU2001250538A1 (en) | Surgical tool | |
AU2001259702A1 (en) | Tissue regrafting | |
AU2002230390A1 (en) | Ixodes scapularis tissue factor pathway inhibitor | |
AU2001283340A1 (en) | Factor viia inhibitors | |
AU4432001A (en) | Trityl-type compounds and their use | |
AUPR099200A0 (en) | New formulation | |
AU2001277236A1 (en) | Shoe construction | |
AUPQ575300A0 (en) | New compound | |
AUPR069500A0 (en) | Tissue modification | |
AU4487001A (en) | Back reamer | |
AU6286101A (en) | New use | |
AU2001274683A1 (en) | Contrast agents | |
AU2001229209A1 (en) | Hydrokeratome for refractive surgery | |
AU2002224528A1 (en) | New use | |
AU5235701A (en) | Sump | |
AU6759601A (en) | Well | |
AU5052701A (en) | Block construction | |
AUPR234400A0 (en) | New compound |